3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
14
Active not recruiting
14
Completed
6
Terminated
2
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Interventions
pembrolizumab
19
Magnetic Resonance Spectroscopy
13
Specimen Handling
12
Cyclophosphamide
10
fludarabine
9
Radiotherapy
9
Biopsy
8
atezolizumab
7
Nivolumab
7
Radiation
6
Prednisone
4
Gemcitabine
4
Etoposide
4
Cytarabine
4
Cisplatin
4
Carboplatin
4
Blood Specimen Collection
4
ALT-803
4
lenvatinib
3
fludarabine phosphate
3
avelumab
3
aldesleukin
3
X-Rays
3
Vincristine
3
Surveys and Questionnaires
3
Rituximab
3
Phantoms, Imaging
3
Paclitaxel
3
Oxaliplatin
3
Lenalidomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
gallium 68 PSMA-11
×
1 year
×
Clear all
NCT06881823
2025-12-29
NeoPSMA
Novartis
Phase 1/2
Withdrawn